Cronos Group (CRON.T) Signs Amended License Deal with Ginkgo Bioworks

Cronos Group (CRON.T) announced today that it has signed an amended and collaboration license agreement with Ginkgo Bioworks that will enable the companies to accelerate the commercialization of cultured cannabinoids at scale. Read full article here: https://equity.guru/2021/06/04/cronos-group-cron-t-signs-amended-license-deal-with-ginkgo-bioworks/